Results 111 to 120 of about 10,605 (184)

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1702-1712, October 2026.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn, Alexandre O. Gérard, Maëlys Labat, Zoe Apalla, Wouter van Binsbergen, Dimitra Koumaki, Valerian Rivet, Frederic Dezoteux, Damien Giacchero, Michael R. Ardern‐Jones, Kara Heelan, Jesse P. Hirner, Ander Mayor, Mariette Labots, Markus V. Starink, Conny J. van der Laken, Vincent Sibaud, Yannick S. Elshot   +17 more
wiley   +1 more source

Achieving Remission in Chronic Rhinosinusitis With Nasal Polyps Depends on Practical Utilization of Current Criteria and Does not Reflect Therapy Response: Results From a Multi‐National Cohort

Clinical and Translational Allergy, Volume 16, Issue 10, October 2026.
Jan Hagemann, Tobias Albrecht, Sanna Toppila‐Salmi, Marie Lundberg, Annina Lyly, Katharina Geißler, Friederike Bärhold, Caroline Beutner, Inga Nierkamp, Mandy Cuevas, Nadine Gunder, Adam Chaker, Moritz Gröger, Ludger Klimek, Sven Becker   +14 more
wiley   +1 more source

Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection. [PDF]

Antibodies (Basel)
Guarino L, Rizzuto G, Coppolelli V, Scipione A, Scattone M, Gargano L, Scribani Rossi P, Del Duca E, Dattola A, Pellacani G, Nisticò S, Chello C.   +11 more
europepmc   +1 more source

Chronic Spontaneous Urticaria in Finland - A Nationwide Registry Study on Epidemiology and Treatment Patterns in Secondary Care. [PDF]

Acta Derm Venereol
Sinikumpu SP, Heikkinen E, Jokelainen J, Roth S, Wolf M, Huilaja L.   +5 more
europepmc   +1 more source

Indications for Biological Treatment Combined with Allergen-Specific Immunotherapy: Who Is It Really Intended for? [PDF]

J Clin Med
Turkalj M, Banić I.
europepmc   +1 more source

A Case Report of Refractory Allergic Bronchopulmonary Aspergillosis: The Art of Selection, Discontinuation and Switching Biologics. [PDF]

J Inflamm Res
Li Y, Yang S, Ren S, Cao P, Zhang Z, Zhang Y.   +5 more
europepmc   +1 more source

Exploring the Potential Benefits of Biologic Therapies Beyond Respiratory Allergy. [PDF]

Immunotargets Ther
Sica R, Catamerò F, Foti Randazzese S, Galletta F, Licari A, Marseglia GL, Mori F, Poto R, Pulvirenti F, Ricci S, Giovannini M, Manti S.   +11 more
europepmc   +1 more source

Pharmacokinetic and Pharmacodynamic Bio-Similarity of ADL-018 to Innovator Omalizumab: A Randomized Study in Healthy Adults. [PDF]

Clin Pharmacol Drug Dev
Soitawala S, Prajapati H, Mehta H, Singh PK.   +3 more
europepmc   +1 more source

Chronic Spontaneous Urticaria in the Era of Targeted Therapy: From Pathogenic Mechanisms to Precision Medicine. [PDF]

Pharmaceutics
Andrzejczak K, Witkowski W, Górka-Dynysiewicz J, Pawłowicz R, Kopeć A.   +4 more
europepmc   +1 more source

Life-Threatening Eosinophilic Granulomatosis With Polyangiitis During Omalizumab Therapy for Chronic Urticaria: Missed Diagnosis, Induction, or Unmasking? [PDF]

Cureus
Zymaris P, Georgopoulou A, Tzioutzia A, Zacharias A, Margaritopoulos G, Sourla E, Boutou A, Pitsiou G.   +7 more
europepmc   +1 more source